Murphy Capital Management Inc Abb Vie Inc. Transaction History

Murphy Capital Management Inc

$720 Million
Q2 2022

A detailed history of Murphy Capital Management Inc transactions in Abb Vie Inc. stock. As of the latest transaction made, Murphy Capital Management Inc holds 5,847 shares of ABBV stock, worth $1.05 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares

5,847

Previous 5,761 1.49%

Holding current value

$1.05 Million

Previous $933,000 4.07%

% of portfolio

0.12%

Previous 0.11%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 13, 2022	BUY	$137.62 - $174.96 $11,835 - $15,046	86 Added 1.49%	5,847 $895,000
Q1 2022 Apr 06, 2022	SELL	$131.98 - $163.75 $791 - $982	-6 Reduced 0.1%	5,761 $933,000
Q4 2021 Jan 10, 2022	SELL	$107.43 - $135.93 $40,071 - $50,701	-373 Reduced 6.07%	5,767 $780,000
Q3 2021 Oct 22, 2021	SELL	$106.4 - $120.78 $5,426 - $6,159	-51 Reduced 0.82%	6,140 $662,000
Q2 2021 Jul 26, 2021	SELL	$105.21 - $117.21 $59,128 - $65,872	-562 Reduced 8.32%	6,191 $697,000
Q1 2021 Apr 21, 2021	BUY	$102.3 - $112.62 $46,137 - $50,791	451 Added 7.16%	6,753 $730,000
Q4 2020 Feb 05, 2021	SELL	$80.49 - $108.67 $48,374 - $65,310	-601 Reduced 8.71%	6,302 $675,000
Q3 2020 Oct 20, 2020	BUY	$85.91 - $100.83 $5,755 - $6,755	67 Added 0.98%	6,903 $604,000
Q2 2020 Aug 03, 2020	BUY	$73.37 - $98.18 $123,334 - $165,040	1,681 Added 32.61%	6,836 $671,000
Q1 2020 Apr 28, 2020	SELL	$64.5 - $97.79 $2,451 - $3,716	-38 Reduced 0.73%	5,155 $392,000
Q4 2019 Feb 10, 2020	SELL	$72.13 - $90.25 $83,815 - $104,870	-1,162 Reduced 18.28%	5,193 $459,000
Q3 2019 Oct 11, 2019	SELL	$62.98 - $75.72 $28,403 - $34,149	-451 Reduced 6.63%	6,355 $481,000
Q2 2019 Jul 22, 2019	SELL	$65.7 - $83.98 $18,724 - $23,934	-285 Reduced 4.02%	6,806 $494,000
Q1 2019 Apr 11, 2019	SELL	$77.14 - $90.79 $57,855 - $68,092	-750 Reduced 9.57%	7,091 $571,000
Q4 2018 Feb 04, 2019	SELL	$77.85 - $96.01 $17,516 - $21,602	-225 Reduced 2.79%	7,841 $722,000
Q3 2018 Oct 10, 2018	SELL	$88.91 - $98.84 $3,111 - $3,459	-35 Reduced 0.43%	8,066 $762,000
Q2 2018 Jul 26, 2018	SELL	$89.78 - $106.23 $132,425 - $156,689	-1,475 Reduced 15.4%	8,101 $750,000
Q1 2018 Apr 17, 2018	SELL	$92.01 - $123.21 $29,903 - $40,043	-325 Reduced 3.28%	9,576 $906,000
Q3 2017 Oct 19, 2017	BUY	$69.85 - $89.22 $691,584 - $883,367	9,901	9,901 $879,000

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Murphy Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Murphy Capital Management Inc with notifications on news.

Account

Murphy Capital Management Inc Abb Vie Inc. Transaction History